Ipraalox

Pantoprazole, the active ingredient in Ipraalox, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to manage acid‑related gastrointestinal conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Ipraalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipraalox, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure, relieving symptoms and promoting healing. - Erosive esophagitis: facilitates mucosal repair and symptom control. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - NSAID‑induced gastric ulcer: aids ulcer healing and prevents recurrence.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional mild upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhoea, abdominal pain. - Acute interstitial nephritis: kidney inflammation, reduced urine output. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: skin blistering and mucosal involvement. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe impairment. - Monitor for drug interactions: especially with clopidogrel, warfarin, and methotrexate. - Use caution in elderly patients: higher risk of fractures and electrolyte disturbances. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Store at room temperature: keep in the original pack, protect from moisture.

Pantoprazole may interact with several medicines; categorisation helps manage risk.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of the antiviral. - High‑dose methotrexate: increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: potential rise in serum levels. - Ciclosporin: may elevate ciclosporin concentrations.